Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
01/06/2011 | US20110002855 Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues |
01/06/2011 | US20110002027 Electrochromic material and electrochromic device including the same |
01/06/2011 | US20110001129 Substituted bipyridyl compound and organic electroluminescent device |
01/06/2011 | CA2766882A1 Therapeutic compounds and compositions |
01/06/2011 | CA2766873A1 Therapeutic compositions and related methods of use |
01/06/2011 | CA2764185A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
01/05/2011 | EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands |
01/05/2011 | EP2270004A1 Caspase inhibitors and uses thereof |
01/05/2011 | EP2270001A1 Indolylmaleimide derivatives as PKC inhibitors |
01/05/2011 | EP2270000A1 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts |
01/05/2011 | EP2269999A1 Method for preparing crystalline s-omeprazole strontium hydrate |
01/05/2011 | EP2269993A1 2-aminoquinazoline derivative |
01/05/2011 | EP2268633A1 Pyridazinone glucokinase activators |
01/05/2011 | EP2268632A1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors |
01/05/2011 | EP2268631A1 Aminopiperidinyl derivatives and uses thereof |
01/05/2011 | EP2268630A2 Hexahydrocyclopentylýf¨indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators |
01/05/2011 | EP2268628A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain |
01/05/2011 | EP2268624A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
01/05/2011 | EP1881977B1 Histone deacetylase inhibitors |
01/05/2011 | EP1633726B1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2 |
01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
01/05/2011 | CN101939313A 3,8-diaminotetrahydroquinoline derivative |
01/05/2011 | CN101939312A Gamma secretase modulators |
01/05/2011 | CN101939311A Heterocyclic compounds with affinity to muscarinic receptors |
01/05/2011 | CN101939302A Mesoionic pesticides |
01/05/2011 | CN101939300A 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
01/05/2011 | CN101939296A Carbazole-containing materials in phosphorescent light emitting diodes |
01/05/2011 | CN101939055A 2-aminoquinolines |
01/05/2011 | CN101939053A Soluble guanylate cyclase activators |
01/05/2011 | CN101935317A Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof |
01/05/2011 | CN101935316A Quinazoline compound and application thereof |
01/05/2011 | CN101935315A Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
01/05/2011 | CN101935303A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors |
01/05/2011 | CN101935301A Modulators of ATP-binding cassette transporters |
01/05/2011 | CN101935298A Bipiridine derivative and organic electroluminescence element containing the same |
01/05/2011 | CN101933926A Indolylmaleimde derivatives as PKC inhibitors |
01/04/2011 | US7863454 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
01/04/2011 | US7863450 e.g. 1-{3-[4-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)phenoxy]propyl}piperidine; histamine H3 receptor antagonist; anxiolytic agent, antidepressant, cognition activator; neurodegenerative diseases, eating disorder, attention deficit disorder, Alzheimer's, Parkinson's diseases, schizophrenia |
01/04/2011 | US7863446 Heterocycles |
01/04/2011 | US7863314 Pyrazole and/or imidazole based compounds; inflammatory diseases and disorders; synthesis |
01/04/2011 | US7863305 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors |
01/04/2011 | US7863293 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count |
01/04/2011 | US7863292 modulators of hypoxia inducible factors and/or endogenous erythropoietin, such as 1-Chloro-4-hydroxy-7-isopropoxy-isoquinoline-3-carboxylic acid (2-hydroxy-1-hydroxymethyl-ethyl)-amide, used for the treatment of anemic disorders, neurological disorders and/or injuries |
01/04/2011 | US7863282 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles |
01/04/2011 | US7863280 poly(ADP-ribose) polymerase (PARP) inhibitors, such as 3-(5-ethyl-2-methyl-6-oxo-1,6-dihydropyridin-3-ylamino)benzonitrile, used for the treatment of ischemia, reperfusion injuries, cardiovascular disorders or myocardium necrosis |
01/04/2011 | US7863266 Therapeutic pyrazoloquinoline urea derivatives |
01/04/2011 | US7863264 Complex of silver and ligand; bactericides, viricides, fungicides |
01/04/2011 | US7863220 Herbicidal pyrimidines |
01/04/2011 | CA2577667C 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase ie |
01/04/2011 | CA2574926C 1,1,2,2-tetra(hetero)arylethanes or 1,1,2-tri(hetero)aryl-2-heterocyclylethanes as potassium channel inhibitors |
01/04/2011 | CA2555331C Therapeutic agents |
01/04/2011 | CA2521271C Quinoline-2-one-derivatives for the treatment of airways diseases |
01/04/2011 | CA2465207C Pyrazole-amides and -sulfonamides |
01/04/2011 | CA2462953C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
01/04/2011 | CA2458533C Imidazole derivates as anti-inflammatory agents |
01/04/2011 | CA2451241C Unsymmetrical cyclic diamine compound |
01/04/2011 | CA2451238C Cyclic diamine compound with 5 membered ring groups |
01/04/2011 | CA2445251C Crystalline form of omeprazole |
01/04/2011 | CA2421228C Polyarylcarboxamides useful as lipid lowering agents |
01/04/2011 | CA2416274C N-phenyl-2-pyrimidine-amine derivatives |
01/04/2011 | CA2413426C Methods and compositions utilizing quinazolinones |
01/04/2011 | CA2412941C Piperidine compounds for use as ccr-3 inhibitors |
01/04/2011 | CA2375008C Phenoxypropylamine compounds |
01/04/2011 | CA2360451C N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance |
01/04/2011 | CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
12/30/2010 | US20100331549 Novel compounds useful for modulating abnormal cell proliferation |
12/30/2010 | US20100331548 Solid-state form of amg 706 and pharmaceutical compositions thereof |
12/30/2010 | US20100331547 Process for making organic compounds and the organic compounds made therefrom |
12/30/2010 | US20100331509 Carbazole-based hole transport and/or electron blocking materials and/or host polymer materials |
12/30/2010 | US20100331375 Biphenyl compounds useful as muscarinic receptor antagonists |
12/30/2010 | US20100331371 Methyl-benzimidazole derivatives |
12/30/2010 | US20100331369 Therapeutic Agents Useful for Treating Pain |
12/30/2010 | US20100331360 3-substituted sulfonyl piperidine derivative |
12/30/2010 | US20100331351 Methods and compositions for treating bacterial infection |
12/30/2010 | US20100331346 Beta-amino acid derivatives for treatment of diabetes |
12/30/2010 | US20100331342 Immuno Inhibitory Pyrazolone Compounds |
12/30/2010 | US20100331339 (1-azinone)-substituted pyridoindoles |
12/30/2010 | US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors |
12/30/2010 | US20100331326 Inhibitors of CYP 17 |
12/30/2010 | US20100331324 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function |
12/30/2010 | US20100331323 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |
12/30/2010 | US20100331317 Benzodiazepine compound and pharmaceutical composition |
12/30/2010 | US20100331312 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
12/30/2010 | US20100331307 Therapeutic compounds and compositions |
12/30/2010 | US20100331306 Heterocyclic compounds and their uses |
12/30/2010 | US20100331304 Compounds Which Modulate The CB2 Receptor |
12/30/2010 | US20100331303 Prolyl hydroxylase inhibitors and methods of use |
12/30/2010 | US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides |
12/30/2010 | US20100331301 Azetidine compound and pharmaceutical use thereof |
12/30/2010 | US20100331298 Carboxamide Compounds and Their Use |
12/30/2010 | US20100331295 Modulators of lxr |
12/30/2010 | US20100331293 Heterocyclic compounds and their uses |
12/30/2010 | US20100330069 Heterocyclic compounds and methods of use |
12/30/2010 | US20100330030 Vasculostatic Agents and Methods of Use Thereof |
12/30/2010 | US20100329998 Novel heterocycles |
12/29/2010 | WO2010151791A1 Heterocyclic compounds and their uses |
12/29/2010 | WO2010151740A2 Heterocyclic compounds and their uses |
12/29/2010 | WO2010151737A2 Heterocyclic compounds and their uses |
12/29/2010 | WO2010151735A2 Heterocyclic compounds and their uses |